A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly
Trial details
- Registry ID
- NCT04522180
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ISIS 766720
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With AcromegalyNCT04522180 | IONS | Phase 2 | Completed | 2022-07-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |